JB
FURX

Julian Baker’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Julian Baker’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-40,309
Closed -$3.51M – 113
2014
Q1 		$3.51M Buy
+40,309
New +$3.11M 0.04% 82

Other funds holding FURX

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Julian Baker's FURX Position: Q2 2014 in Review

Julian Baker sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q2 2014, closing a stake of 40,309 shares — an estimated $3.51M sold.

Julian Baker first reported a position in FURX in Q1 2014 and held it in 1 quarter. The position peaked at $3.51M in Q1 2014. 102 funds tracked by Wall St. Rank hold FURX as of Q2 2014.

  • Julian Baker reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2014 after selling out during the quarter.
  • Julian Baker sold 40,309 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2014, an estimated $3.51M.
  • Julian Baker first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 1 quarter.
  • Julian Baker's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $3.51M in Q1 2014.
  • 102 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2014.

Based on Baker Bros. Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.